Investor meeting intimation
Awaiting price reaction for this filing.
Eris Lifesciences Limited has informed stock exchanges about an upcoming group meeting with investors scheduled for Monday, May 26, 2025. The interaction will be held in-person with an Investor Group. The company has clarified that only publicly available documents will be referenced during the discussion, and no unpublished price-sensitive information (UPSI) will be shared. An unedited audio/video recording of the meeting will be kept at the registered office for regulatory inspection. The schedule is indicative and may change due to unforeseen circumstances.
This is a routine regulatory disclosure about a scheduled investor engagement and is unlikely to have any immediate impact on the stock price. Investors should note that no new or price-sensitive information is expected to be shared at this meeting.